{"cdcTestId":"2013-0231","testcaseName":"Dose # 3 at age 24 weeks-4 days.  Series complete. ","vaccineGroup":"HepB","evaluationTestType":"Age: At Absolute Minimum","forecastTestType":"Not recommended: series complete","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2022-05-08T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2022-05-08T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-06-08T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-05-08T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-06-08T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-06-18T08:12:13.529","generalDescription":"This test case describes when dose #3 of the Hep B vaccine is administered at 24 weeks - 4 days of age, that the series is complete. ","changedInVersion":"1.0","reasonForChange":""}